We are live on ! Find out more
KBG

Kahn Brothers Group Portfolio holdings

AUM $564M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+25.3%
3 Year Est. Return
+38.07%
5 Year Est. Return
+72.96%
10 Year Est. Return
+308.37%
AUM
$728M
AUM Growth
+$17.7M
Cap. Flow
+$13.3M
Cap. Flow %
1.83%
Top 10 Hldgs %
83.73%
Holding
43
New
Increased
17
Reduced
13
Closed

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$4.05M
2
GSK icon
GSK
GSK
+$3.55M
3
BMY icon
Bristol-Myers Squibb
BMY
+$2.81M
4
VRAY
ViewRay, Inc.
VRAY
+$2.17M
5
PFE icon
Pfizer
PFE
+$1.83M

Top Sells

Rank Stock Value
1
BB icon
BlackBerry
BB
+$1.76M
2
BP icon
BP
BP
+$1.12M
3
RFL icon
Rafael Holdings
RFL
+$392K
4
HOLX
Hologic
HOLX
+$226K
5
SEB icon
Seaboard Corp
SEB
+$119K

Sector Composition

Rank Sector Weight
1 Financials 37.69%
2 Healthcare 33.39%
3 Energy 15.29%
4 Consumer Staples 5.48%
5 Technology 3.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBI icon
1
MBIA
MBI
$333M
$78.6M 10.8%
4,978,900
+11,067
+0.2% +$146K
AGO icon
2
Assured Guaranty
AGO
$3.76B
$72.1M 9.9%
1,435,845
+3,420
+0.2% +$176K
GSK icon
3
GSK
GSK
$104B
$63.4M 8.71%
1,150,855
+68,169
+6% +$3.55M
PFE icon
4
Pfizer
PFE
$143B
$60.1M 8.26%
1,017,928
+36,940
+4% +$1.83M
BP icon
5
BP
BP
$108B
$59.7M 8.2%
2,240,889
-40,545
-2% -$1.12M
FLG
6
Flagstar Bank National Association
FLG
$6.21B
$59.6M 8.18%
1,625,880
+27,756
+2% +$1.06M
BMY icon
7
Bristol-Myers Squibb
BMY
$124B
$57.5M 7.89%
921,603
+47,873
+5% +$2.81M
MRK icon
8
Merck
MRK
$315B
$54.4M 7.47%
709,224
+3,041
+0.4% +$242K
C icon
9
Citigroup
C
$217B
$54M 7.41%
893,788
+60,852
+7% +$4.05M
PTEN icon
10
Patterson-UTI
PTEN
$3.8B
$50.3M 6.91%
5,956,377
-1,987
-0% -$17.1K
SEB icon
11
Seaboard Corp
SEB
$4.34B
$39.5M 5.43%
10,048
-30
-0.3% -$119K
VOXX
12
DELISTED
VOXX International Corporation Class A
VOXX
$20.6M 2.83%
2,023,059
+69,749
+4% +$776K
STL
13
DELISTED
Sterling Bancorp
STL
$6.98M 0.96%
270,498
-2,521
-0.9% -$65.2K
VRAY
14
DELISTED
ViewRay, Inc.
VRAY
$5.07M 0.7%
920,200
+357,045
+63% +$2.17M
TPHS
15
DELISTED
Trinity Place Holdings Inc.com
TPHS
$2.71M 0.37%
1,473,462
+121,163
+9% +$237K
HOLX
16
DELISTED
Hologic
HOLX
$2.49M 0.34%
32,539
-3,080
-9% -$226K
OGN icon
17
Organon & Co
OGN
$3.55B
$2.1M 0.29%
68,870
-1,294
-2% -$42.1K
NVS icon
18
Novartis
NVS
$293B
$1.96M 0.27%
22,378
+1,980
+10% +$164K
BB icon
19
BlackBerry
BB
$5.27B
$1.44M 0.2%
1,543,947
-175,570
-10% -$1.76M
RFL icon
20
Rafael Holdings
RFL
$112M
$1.44M 0.2%
286,969
-29,130
-9% -$392K
VTRS icon
21
Viatris
VTRS
$20.1B
$1.19M 0.16%
88,280
+188
+0.2% +$2.51K
ZDGE icon
22
Zedge
ZDGE
$39.1M
$1.07M 0.15%
123,179
+834
+0.7% +$9.14K
BRK.B icon
23
Berkshire Hathaway Class B
BRK.B
$1.06T
$972K 0.13%
3,250
XOM icon
24
ExxonMobil
XOM
$611B
$952K 0.13%
15,564
VZ icon
25
Verizon
VZ
$182B
$816K 0.11%
15,714
-550
-3% -$28.7K

Similar funds

Kahn Brothers Group's Q4 2021 Portfolio in Review

As of Q4 2021, Kahn Brothers Group held 43 positions worth $728M, up 2.5% from $710M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 0%. Kahn Brothers Group opened no new positions and made no exits, leaving the 43-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Energy.

  • Kahn Brothers Group added most to Citigroup in Q4 2021, an estimated $4.05M increase.
  • Kahn Brothers Group's biggest Q4 2021 reduction was BlackBerry, cutting an estimated $1.76M.
  • Kahn Brothers Group's ten largest holdings make up 84% of its $728M portfolio in Q4 2021.
  • Kahn Brothers Group opened 0 new positions and closed 0 in Q4 2021.
  • Kahn Brothers Group's portfolio value rose 2.5% quarter-over-quarter to $728M.

Based on Kahn Brothers Group's 13F filing for Q4 2021, filed 25 Jan 2022.